Navegar

Colección

Datos Estadísticas

Lista de

multiple myeloma
7
"Expression profile of shelterin components in plasma cell disorders. Clinical significance of POT1 overexpression" (2014) Panero, J.;Stanganelli, C.;Arbelbide, J. (...)Slavutsky, I. Blood Cells, Molecules, and Diseases. 52(2-3):134-139
"Expression profile of shelterin components in plasma cell disorders. Clinical significance of POT1 overexpression" (2014) Panero, J.;Stanganelli, C.;Arbelbide, J. (...)Slavutsky, I. Blood Cells, Molecules, and Diseases. 52(2-3):134-139
"Expression profile of shelterin components in plasma cell disorders. Clinical significance of POT1 overexpression" (2014) Panero, J.;Stanganelli, C.;Arbelbide, J. (...)Slavutsky, I. Blood Cells, Molecules, and Diseases. 52(2-3):134-139
"Expression profile of shelterin components in plasma cell disorders. Clinical significance of POT1 overexpression" (2014) Panero, J.;Stanganelli, C.;Arbelbide, J. (...)Slavutsky, I. Blood Cells, Molecules, and Diseases. 52(2-3):134-139
"Galectins in hematological malignancies" (2013) Giordano, M.; Croci, D.O.; Rabinovich, G.A. Current Opinion in Hematology. 20(4):327-335
"Vascular galectins: Regulators of tumor progression and targets for cancer therapy" (2013) Thijssen, V.L.; Rabinovich, G.A.; Griffioen, A.W. Cytokine and Growth Factor Reviews. 24(6):547-558
"Tumor-specific MAGE proteins as regulators of p53 function" (2012) Ladelfa, M.F.;Peche, L.Y.;Toledo, M.F. (...)Monte, M. Cancer Letters. 325(1):11-17